ALBNYSEBasic Materials

ALBEMARLE CORP

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$99.25

+0.89%

Alpha Vantage · 11/6/2026

Industry: Specialty ChemicalsCategory: Domestic Common Stock Primary ClassCurrency: USDNews: 1 recent

Analyze ALB free

One-year price history

Adjusted daily closes · 252 observations · as of Nov 6, 2026

Historical data, not a forecast

1 month

-2.8%

3 months

-24.1%

6 months

-51.0%

1 year

+10.0%

Year to date

-29.2%

52-week range

$90.19 – $214.36

Fundamental snapshot

Latest reported period: Sep 30, 2026

Sharadar reported data

Market cap

$11.71B

P/E

22.7

P/B

1.1

P/S

1.9

Revenue

$6.15B

Net income

$681.63M

Diluted EPS

4.13

Gross margin

25.80%

Net margin

8.40%

Return on equity

5.10%

Total debt

$1.88B

Cash

$1.85B

Free cash flow

$1.45B

Latest eight reported quarters

Reported quarterly values, newest first

Period	Revenue	Net income	Gross margin	Net margin	Free cash flow
Sep 30, 2026	$1.55B	$296.76M	19.40%	16.40%	$325.42M
Jun 30, 2026	$1.74B	$479.96M	33.90%	25.10%	$638.27M
Mar 31, 2026	$1.43B	$319.09M	35.10%	19.40%	$247.57M
Dec 31, 2025	$1.43B	-$414.18M	13.90%	-31.90%	$240.26M
Sep 30, 2025	$1.31B	-$160.69M	9.00%	-15.50%	$225.34M
Jun 30, 2025	$1.33B	$22.9M	14.80%	-1.40%	-$103.08M
Mar 31, 2025	$1.08B	$41.35M	14.50%	0.00%	$362.76M
Dec 31, 2024	$1.23B	$75.29M	11.20%	2.70%	-$325.95M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent ALB news

All market news

TradingView·Nov 6, 202655 signal

RBC Capital maintains Albemarle at Outperform, lowers price target to $119 from $129

RBC Capital has reaffirmed its "Outperform" rating for Albemarle (ALB) but has reduced its price target to $119 from $129, representing a 7.8% decrease. This new price target suggests a potential upside of 21.0% from the stock's closing price of $98.37 on November 5. The article also provides a summary of recent analyst actions on Albemarle, with price targets ranging from $95 to $185 over the past 30 days.

Original source